CAPS Key Stats
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu 11/21 09:01 ET
- Capstone Therapeutics Announces a LipimetiX Development, LLC Presentation at the American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit of AEM-28 on Established Atherosclerotic Les noodls 11/19 12:14 ET
- Capstone Therapeutics to Hold Quarterly Operating Update Conference Call noodls 11/12 16:26 ET
- CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report 11/12 10:58 ET
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu 08/14 08:31 ET
- Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results GlobeNewswire 08/14 08:30 ET
- Q2 2013 Capstone Therapeutics Earnings Release - Time Not Supplied 08/14 07:07 ET
- Capstone Therapeutics to Hold Quarterly Operating Update Conference Call GlobeNewswire 08/07 14:16 ET
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders 06/17 06:35 ET
- Capstone Therapeutics Corp. Part-Owner Buys 300K Shares and 4 Insider Buys to Note 06/12 09:19 ET
CAPS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Capstone Therapeutics is up 20.05% over the last year vs S&P 500 Total Return up 24.21%, ARCA biopharma down 21.49%, and Xencor up N/A.
Balance Sheet View Statement
Pro Ratings for CAPS
Pro Strategies Featuring CAPS
Did Capstone Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Arizona
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Capstone Therapeutics Corp is a biotechnology company developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions.